SHAREHOLDERS' EQUITY |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Stockholders' Equity Note [Abstract] | |
| SHAREHOLDERS' EQUITY | SHAREHOLDERS’ EQUITY Share Repurchase Authorization In November 2022, the Company’s Board of Directors authorized the repurchase of up to 10,000,000 shares of its common stock, including shares to be repurchased under Rule 10b5–1. As of June 30, 2026, 3,454,001 shares remained to be repurchased under the Company’s repurchase authorization. The Company intends to repurchase all shares under its authorization, for which no expiration date has been established, in open market or privately negotiated transactions, subject to market conditions. Share Repurchases During the first six months of 2026, the Company reacquired 2,538,433 shares of its common stock, of which 2,442,820 related to share repurchases through open market and 95,613 related to shares withheld for taxes on the exercise of stock options and the vesting of stock awards and units. During the first six months of 2025, the Company reacquired 801,780 shares of its common stock, of which 730,312 related to share repurchases through open market and 71,468 related to shares withheld for taxes on the exercise of stock options and the vesting of stock awards and units.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|